Methodological, biological and clinical aspects of circulating free DNA in metastatic colorectal cancer
出版年份 2016 全文链接
标题
Methodological, biological and clinical aspects of circulating free DNA in metastatic colorectal cancer
作者
关键词
-
出版物
ACTA ONCOLOGICA
Volume 56, Issue 1, Pages 7-16
出版商
Informa UK Limited
发表日期
2016-12-25
DOI
10.1080/0284186x.2016.1253861
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A systematic review and meta-analysis of the prognostic value of total cell-free DNA quantification in metastatic colorectal cancer
- (2016) K.-L.G. Spindler et al. ANNALS OF ONCOLOGY
- Increased Free Circulating DNA Integrity Index as a Serum Biomarker in Patients with Colorectal Carcinoma
- (2016) Dina El-Gayar et al. Asian Pacific Journal of Cancer Prevention
- Characterization of the cell-free DNA released by cultured cancer cells
- (2016) Abel Jacobus Bronkhorst et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The prognostic value of lactate dehydrogenase levels in colorectal cancer: a meta-analysis
- (2016) Guanghua Li et al. BMC CANCER
- Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin
- (2016) Matthew W. Snyder et al. CELL
- Global patterns and trends in colorectal cancer incidence and mortality
- (2016) Melina Arnold et al. GUT
- Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
- (2015) M. P. Morelli et al. ANNALS OF ONCOLOGY
- Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
- (2015) J. Tie et al. ANNALS OF ONCOLOGY
- Controls to validate plasma samples for cell free DNA quantification
- (2015) Niels Pallisgaard et al. CLINICA CHIMICA ACTA
- Cell-free DNA: Preanalytical variables
- (2015) Abel Jacobus Bronkhorst et al. CLINICA CHIMICA ACTA
- Improved sensitivity of circulating tumor DNA measurement using short PCR amplicons
- (2015) Rikke Fredslund Andersen et al. CLINICA CHIMICA ACTA
- EDTA-mediated inhibition of DNases protects circulating cell-free DNA from ex vivo degradation in blood samples
- (2015) Gustavo Barcelos Barra et al. CLINICAL BIOCHEMISTRY
- Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration
- (2015) J. S. Frenel et al. CLINICAL CANCER RESEARCH
- Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer
- (2015) David Sefrioui et al. DIGESTIVE AND LIVER DISEASE
- Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapy
- (2015) Karen-Lise Garm Spindler et al. EUROPEAN JOURNAL OF CANCER
- Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib
- (2015) Andrea Wong et al. Journal of Translational Medicine
- Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial
- (2015) Josep Tabernero et al. LANCET ONCOLOGY
- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
- (2015) M. Russo et al. Cancer Discovery
- Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform
- (2015) Evelyn Kidess et al. Oncotarget
- Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
- (2015) Filip Janku et al. Oncotarget
- Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review
- (2015) Benoist Chibaudel et al. Therapeutic Advances in Medical Oncology
- Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
- (2015) Karen Lise Garm Spindler et al. PLoS One
- Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification
- (2014) Alison S. Devonshire et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
- (2014) T B Hao et al. BRITISH JOURNAL OF CANCER
- Circulating Tumor DNA as a Liquid Biopsy for Cancer
- (2014) E. Heitzer et al. CLINICAL CHEMISTRY
- Changes in mutational status during third-line treatment for metastatic colorectal cancer-Results of consecutive measurement of cell free DNA,KRASandBRAFin the plasma
- (2014) Karen-Lise Garm Spindler et al. INTERNATIONAL JOURNAL OF CANCER
- Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer
- (2014) Karen-Lise Garm Spindler et al. INTERNATIONAL JOURNAL OF CANCER
- KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer
- (2014) Jian-Ming Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types
- (2014) Ronald Lebofsky et al. Molecular Oncology
- Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
- (2014) Alain R Thierry et al. NATURE MEDICINE
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing
- (2014) Sumitra Mohan et al. PLoS Genetics
- Phase II trial of temsirolimus alone and in combination with irinotecan forKRASmutant metastatic colorectal cancer: Outcome and results ofKRASmutational analysis in plasma
- (2013) Karen-Lise G. Spindler et al. ACTA ONCOLOGICA
- The correlation between cell-free DNA and tumour burden was estimated by PET/CT in patients with advanced NSCLC
- (2013) A D Nygaard et al. BRITISH JOURNAL OF CANCER
- KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer
- (2013) K G Spindler et al. BRITISH JOURNAL OF CANCER
- Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer
- (2013) S.H. Lim et al. CANCER LETTERS
- Circulating cell free DNA: Preanalytical considerations
- (2013) Safia El Messaoudi et al. CLINICA CHIMICA ACTA
- Multiplex Picodroplet Digital PCR to Detect KRAS Mutations in Circulating DNA from the Plasma of Colorectal Cancer Patients
- (2013) V. Taly et al. CLINICAL CHEMISTRY
- Circulating cell-free DNA in serum as a biomarker of colorectal cancer
- (2013) Benisio Ferreira da Silva Filho et al. JOURNAL OF CLINICAL PATHOLOGY
- Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients
- (2012) L. Benesova et al. ANALYTICAL BIOCHEMISTRY
- Ultrasensitive Measurement of Hotspot Mutations in Tumor DNA in Blood Using Error-Suppressed Multiplexed Deep Sequencing
- (2012) A. Narayan et al. CANCER RESEARCH
- Alu-based cell-free DNA: A potential complementary biomarker for diagnosis of colorectal cancer
- (2012) Jing Qi et al. CLINICAL BIOCHEMISTRY
- Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
- (2012) K.-L. G. Spindler et al. CLINICAL CANCER RESEARCH
- The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients
- (2012) Florent Mouliere et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Digital PCR strategies in the development and analysis of molecular biomarkers for personalized medicine
- (2012) Elizabeth Day et al. METHODS
- Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers
- (2012) Geraldine Perkins et al. PLoS One
- Measurement of Circulating Cell-Free DNA Levels by a New Simple Fluorescent Test in Patients With Primary Colorectal Cancer
- (2011) David Czeiger et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Circulating tumour markers can define patients with normal colons, benign polyps and cancers
- (2011) R Mead et al. BRITISH JOURNAL OF CANCER
- Methods for isolation of cell-free plasma DNA strongly affect DNA yield
- (2011) Michael Fleischhacker et al. CLINICA CHIMICA ACTA
- Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer
- (2011) Leticia De Mattos-Arruda et al. Future Oncology
- Quantitative and sensitive detection of rare mutations using droplet-based microfluidics
- (2011) Deniz Pekin et al. LAB ON A CHIP
- Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literature
- (2010) Klaus Jung et al. CLINICA CHIMICA ACTA
- Real-time polymerase chain reaction quantification of free DNA in serum of patients with polyps and colorectal cancers
- (2010) Elisa Danese et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Predictive and prognostic value of KRAS mutations in metastatic colorectal cancer patients treated with cetuximab: A meta-analysis of 22 studies
- (2010) Li-Xin Qiu et al. EUROPEAN JOURNAL OF CANCER
- Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
- (2010) Alain R. Thierry et al. NUCLEIC ACIDS RESEARCH
- Detection of Mutated K-rasDNA in Urine, Plasma, and Serum of Patients with Colorectal Carcinoma or Adenomatous Polyps
- (2009) Ying-Hsiu Su et al. Annals of the New York Academy of Sciences
- Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?
- (2009) Maniesh van der Vaart et al. CLINICAL BIOCHEMISTRY
- Detection of KRAS Oncogene in Peripheral Blood as a Predictor of the Response to Cetuximab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer
- (2009) L.-C. Yen et al. CLINICAL CANCER RESEARCH
- Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer
- (2008) M. Frattini et al. CANCER LETTERS
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Cell-free DNA resuscitated for tumor testing
- (2008) Michael Fleischhacker et al. NATURE MEDICINE
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
- The concentration of deoxyribonucleic acid in plasma from 73 patients with colorectal cancer and apparent clinical correlations
- (2008) Héctor Guadalajara et al. Cancer Detection and Prevention
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started